Breakthrough Chemistry, Inc. (BKTH)
0.208
0.00 (0.00%)
USD |
OTCM |
Aug 31, 16:00
Breakthrough Chemistry Total Long Term Debt (Quarterly) : 0.00 for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.00 |
| March 31, 2026 | 0.00 |
| December 31, 2025 | 0.00 |
| September 30, 2025 | 0.00 |
| June 30, 2025 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| October 31, 2014 | 0.00 |
| July 31, 2014 | 0.00 |
| April 30, 2014 | 0.00 |
| January 31, 2014 | 0.00 |
| Date | Value |
|---|---|
| October 31, 2013 | 0.00 |
| July 31, 2013 | 0.00 |
| April 30, 2013 | 0.00 |
| January 31, 2013 | 0.00 |
| October 31, 2012 | 0.00 |
| July 31, 2012 | 0.00 |
| April 30, 2012 | 0.00 |
| January 31, 2012 | 0.1001M |
| October 31, 2011 | 0.1001M |
| July 31, 2011 | 0.00 |
| April 30, 2011 | 0.0835M |
| January 31, 2011 | 0.00 |
| October 31, 2010 | 0.00 |
| July 31, 2010 | 0.02M |
| April 30, 2010 | 0.00 |
| January 31, 2010 | 0.00 |
| October 31, 2009 | 0.00 |
| July 31, 2009 | 0.00 |
| April 30, 2009 | 0.00 |
| January 31, 2009 | 0.4716M |
| October 31, 2008 | 0.5417M |
| July 31, 2008 | 0.00 |
| April 30, 2008 | 0.00 |
| January 31, 2008 | 0.00 |
| October 31, 2007 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Cardiac Biotech Solutions, Inc. | 0.00 |
| Precision Optics Corp., Inc. | 3.965M |
| Petros Pharmaceuticals, Inc. | 0.00 |
| RxSight, Inc. | 8.947M |
| Vyome Holdings, Inc. | 0.00 |